Insulin glargine-lixisenatide Significantly Improves Blood Sugar Control in Insulin-Naive Adults with Type 2 Diabetes: Study Medha Baranwal12 March 2025 9:30 AM ISTUSA: A study published in Diabetes, Obesity and Metabolism found that insulin glargine-lixisenatide (iGlarLixi) significantly improves time-in-range...
Insulin Degludec: A Safer, More Effective Option for Managing Critical Illness Hyperglycemia, Study Finds Medha Baranwal22 Jan 2025 8:30 AM ISTEgypt: A recent study published in the Indian Journal of Critical Care Medicine has compared the efficacy of ultra-long-acting insulin degludec with...
Which is better- Once-daily or twice-daily insulin glargine in noncritically ill population? Medha Baranwal23 May 2024 10:00 AM ISTUSA: In a comprehensive retrospective analysis published in Diabetes Spectrum, researchers have delved into the dosing frequency of Insulin Glargine,...
Diabetes drug: Sanofi unveils Soliqua in India Ruchika Sharma30 April 2024 2:35 PM ISTSoliqua is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting basal insulin and lixisenatide, a...
Biocon obtains approval for diabetes drug Liraglutide in UK Ruchika Sharma28 March 2024 2:30 PM ISTBengaluru: Biocon Limited, a global biopharmaceuticals company, has announced that the Company has received approval from the Medicines and...
CDSCO Panel revises warning statement of Sanofi's antidiabetic FDC Insulin Glargine plus Lixisenatide Dr. Divya Colin13 Dec 2023 6:00 PM ISTNew Delhi: Approving the amendment in the warning statement for Sanofi's Fixed Ratio Combination of Insulin Glargine 100U/mL plus Lixisenatide 50...
Novel GLP-1R agonist beinaglutide exhibits favourable hypoglycemic effect in patients with type 2 diabetes Medha Baranwal24 Oct 2023 11:00 AM ISTChina: A multicenter, open-label, randomized trial has shown that a new GLP-1RA, beinaglutide, exhibits a favourable hypoglycemic effect on patients...
Once-weekly insulin icodec better than once-daily insulin glargine for patients with type 2 diabetes: ONWARDS 4 trial Medha Baranwal12 May 2023 12:00 PM ISTBelgium: Once-weekly insulin icodec performed equally well as once-daily insulin glargine U100 for glycemic control, required fewer basal insulin...
NPPA Fixes Ceiling Price Of Disposable pen containing insulin glargine Susmita Roy16 April 2023 6:00 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed a ceiling price of Rs. 217.74 per ml for Insulin Glargine 100IU/ml Pens,...
Diabetes drug: Sanofi gets marketing authorization from CDSCO for Soliqua Ruchika Sharma28 March 2023 3:14 PM ISTSoliqua (10-40 and 30-60 prefilled pens) is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting...
Tirzepatide better than glargine for improving kidney outcomes in type 2 diabetes: SURPASS-4 trial Medha Baranwal3 Oct 2022 6:00 PM ISTUSA: Tirzepatide slows the estimated glomerular filtration rate (eGFR) decline and reduces the urine albumin-creatinine ratio (UACR) in type 2...
Liraglutide and insulin glargine score over other diabetes drugs for diabetics already maintained on metformin Medha Baranwal24 Sept 2022 10:00 AM ISTLiraglutide and insulin glargine performed the best of other FDA-approved glucose-lowering medications to maintain blood glucose levels in the...
